Your Lipid Clinic for Today – Wave 1

This course is designed for physicians who specialise in cardiovascular disease, endocrinology, and internal medicine, and whose role involves diagnosis and management of dyslipidaemias.

Learning is by means of a series of case presentations based on real patient cases. As in real-world practice, course participants gradually get to know the patients’ medical histories, current medications, lab results, physical exam results, and family backgrounds, and must work out the correct diagnosis and suitable treatment for their fictive patients.

For each case, participants are asked to propose a preliminary diagnosis. They can then refine this as more information about the patient is revealed, a format that reinforces the participant’s clinical reasoning and builds confidence in therapeutic decision-making.

Each case concludes with the presenter giving insights and guidelines-recommended management strategies, so the participant can compare their own approach.

Whether you’re looking to refresh your knowledge or deepen your expertise, this course offers a practical and compelling way to advance your care of patients with lipid disorders.

Course structure

The course is divided into waves, each comprising four case studies. Each case study takes about 15 minutes to go through, and includes multiple-choice questions. The participant is awarded a certificate after correctly answering all the questions in a wave. New waves will be released over time.

Language

Presentations are given in English.

Details

Date of preparation: October 30, 2025
Last revised: November 3, 2025
Expiry date: February 2, 2028

By participating in this programme, you will improve your ability to:

• Recognize and interpret key clinical features of various lipid disorders through realistic case presentations.
• Analyze patient history, physical examination findings, and family background to formulate preliminary diagnoses.
• Integrate laboratory results to refine diagnostic accuracy and identify specific dyslipidaemia subtypes.
• Apply evidence-based strategies to manage lipid disorders, including pharmacological and lifestyle interventions.

Lipid clinics are specialized healthcare settings that focus on managing and treating lipid disorders. As a professional in this environment your role is multi-faceted and contributes significantly to the overall success of the management of the patient and the clinic’s ability to provide patient-centred care.

This training programme from EAS is created for an audience of professionals working in a lipid clinic.

It is also relevant to professionals working in cardiovascular prevention, in diabetes and in other clinics, who come across patients with cardiovascular or metabolic diseases on a regular basis.

ACLF – Acute on Chronic Liver Failure
Acrp30 – Adiponectin
ACS – Acute Coronary Syndrome
ADA – American Diabetes Association
ADMA – asymmetrical dimethylarginine
AGE – Advanced glycation end product
AGEs – Advanced Glycation Endproducts
AGI – Alpha Glucosidase Inhibitors
alpha 2-beta AR – alpha 2-beta adrenergic receptors
ALT – Alanine Aminotransferase
AMPK – Adenosine Monophosphate activated Protein Kinase
apM1 – Adiponectin
ARB – Angiotensin Receptor Blocker
ATP III – Adult Treatment Panel
BAD – Brachial Artery Distensibility
BCDI – Beta-Cell Demand Index
BCS – Budd-Chiari Syndrome
BDA – British Diabetic Association
BIP – Bezafibrate Infarction Prevention
BMI – Body Mass Index
CAD – Coronary Artery Disease
cccDNA – closed circular DNA
CCK – Cholecystokinin
CHD – Coronary Heart Disease
CHF – Congestive Heart Failure
CLA – Conjugated Linoleic Acid
CNTF – Ciliary Neurotrophic Factor
CRP – C reactive protein
CVD – cardiovascular disease
DASIMAR – the summed product of ADMA and SDMA
DASIMAR – score
DASIMAR – score of the sum of DAS and IMAR
DKA – Diabetic Ketoacidosis
DM – diabetes mellitus
DPP – Diabetes Prevention Program
EBL – Endoscopic band ligation
EGIR – European Group for the study of Insulin Resistance
EWET – Enlarged Waist with Elevated Triacylglycerols
FA – Fatty Acid
FAAH – Fatty Acid Amide Hydrolase
FBG – fasting blood glucose
FDA – Food and Drug Agency
FFAs – Free Fatty Acids
FIAF – Fasting Induced Adipose Factor
FMD – Flow-Mediated Dilation
FPG – fasting plasma glucose
FPI – Fasting Plasma Insulin
GI – Glycemic Index
GIK Therapy – Glucose-Insulin-Potassium Therapy
HbA1c – Glycosylated Hemoglobin A1C
HDL – high-density lipoprotein
HMO – Health Maintenance Organization
HOMA – Homeostasis Model Assessment
HPA – Hypothalamic-Pituitary-Adrenal
HRS – hepatorenal syndrome
HVPG – hepatic venous pressure gradient
IAPP – islet amyloid polypeptide
ICCU – Intensive Cardiac Care Unit
IDF – International Diabetes Federation
IFH – isolated fasting hyperglycemia
IGR – impaired glucose regulation
IGT – impaired glucose tolerance
IL-6 – Interleukin-6
IMCL – Intramyocellular Lipids
IMT – Intima-media Thickness
IPH – isolated postchallenge hyperglycemia
IPMN – intraductal papillary mucinous neoplasm
LDL – low-density lipoprotein
LDLT – Living donor liver transplantation
MGSD – Mediterranean Group for the Study of Diabetes
MI – Myocardial Infarction
NCEP – National Cholesterol Education Program
NGR – Normal glucose regulation
NGT – Normal glucose tolerance
NHS – Nurses’ Health Study
OGTT – Oral Glucose Tolerance Test
PAI-1 – Plasminogen Activator Inhibitor Type 1
PGC-1 alpha – peroxisome proliferator-activated receptor gamma coactivator-1 alpha
PMN – Polymorphonuclear Neutrophil
PPAR gamma – peroxisome proliferator activated receptors
PPG – Postprandial Glucose
PSA – Prostate specific antigen
PWV – Pulse Wave Velocity
PWV – Pulse Wave Velocity
QOL – Quality of life
RAGE – Receptor for AGE
RAI – Radioactive iodine
RAI Scanning – Radioactive Iodine Scanning
RECIST – Response Evaluation Criteria In Solid Tumors
RNAi – RNA interference
RR – Relative risk
RXR – retinoid X receptors
SAA – Serum Amyloid A
SADLE – San Antonio Diabetes Likelihood Equation
SCL – Sclerotherapy
SDMA – symmetric dimethylarginine
SIRS – Systemic inflammatory response syndrome
SOFA – Sepsis-related Organ Failure Assessment
SU – sulfonylurea
T2D – type 2 diabetes
T4/T3 – Thyroxine
TERalb – Transcapillary Escape Rate of Albumin
TG – triglyceride
TIPS – Transjugular intrahepatic portosystemic shunt
TNF-alpha – Tumor Necrosis Factor alpha
TZD – Thiazolidinedione
UCP2 – Uncoupling Protein 2
VIP – Vasterbotten Intervention Program
VSMC – Vascular Smooth Muscle Cells
WC – Waist Circumference
WHO – World Health Organization

Your Lipid Clinic for Today – Wave 1 (ELM/2025/00228) has been accredited by the EACCME®, the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

Each medical specialist should claim only those credits that he/she actually spent in the educational activity.

The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited.

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits(TM).

Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Scientific Directors

Professor Evangelos Liberopoulos, Professor of Medicine – Metabolic Diseases in the School of Medicine, National and Kapodistrian University of Athens, Greece

Professor Kirsten B. Holven, Head of Section of Clinical Nutrition, Department of Nutrition, University of Oslo and a researcher at the National Advisory Unit on Familial Hypercholesterolemia (FH), Oslo University Hospital, Norway